The Impact of TP53 Mutations and Use of the TP53Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate Cancer

被引：0
|
作者：
Hoang, T. [1 ]
Sutera, P. [2 ]
Nguyen, T. [1 ]
Chang, J. H. [3 ]
Jagtap, S. [3 ]
Song, Y. [3 ]
Shetty, A. [3 ]
Chowdhury, D. D. [3 ]
Chan, A. [3 ]
Carrieri, F. A. A. [4 ]
Song, D. [5 ]
DeWeese, T. L. [5 ]
Lafargue, A. [5 ]
Van der Eecken, K. [6 ]
Bunz, F. [7 ]
Ost, P. [8 ]
Tran, P. T. [5 ,9 ]
Deek, M. P. [10 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Univ Maryland, Baltimore, MD 21201 USA
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[6] Univ Ghent, Ghent, Belgium
[7] Johns Hopkins Med, Baltimore, MD USA
[8] Ghent Univ Hosp, Dept Radiat Oncol, Ghent, Belgium
[9] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA
[10] Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2966
引用
收藏
页码：E443 / E443
页数：1
相关论文
共 50 条
  • [21] Impact of TP53 mutations in Triple Negative Breast Cancer
    Zahi I. Mitri
    Nour Abuhadra
    Shaun M. Goodyear
    Evthokia A. Hobbs
    Andy Kaempf
    Alastair M. Thompson
    Stacy L. Moulder
    npj Precision Oncology, 6
  • [22] Impact of TP53 mutations in Triple Negative Breast Cancer
    Mitri, Zahi, I
    Abuhadra, Nour
    Goodyear, Shaun M.
    Hobbs, Evthokia A.
    Kaempf, Andy
    Thompson, Alastair M.
    Moulder, Stacy L.
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [23] Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
    Meric-Bernstam, Funda
    Zheng, Xiaofeng
    Shariati, Maryam
    Damodaran, Senthil
    Wathoo, Chetna
    Brusco, Lauren
    Demirhan, Mehmet Esat
    Tapia, Coya
    Eterovic, Agda Karina
    Basho, Reva K.
    Ueno, Naoto T.
    Janku, Filip
    Sahin, Aysegul
    Rodon, Jordi
    Broaddus, Russell
    Kim, Tae-Beom
    Mendelsohn, John
    Shaw, Kenna R. Mills
    Tripathy, Debu
    Mills, Gordon B.
    Chen, Ken
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 15
  • [24] Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer
    Netter, Jeanne
    Lehmann-Che, Jacqueline
    Lambert, Jerome
    Tallet, Anne
    Lourenco, Nelson
    Soliman, Hany
    Bertheau, Philippe
    Pariente, Benjamin
    Chirica, Mircea
    Pocard, Marc
    Allez, Matthieu
    De The, Hugues
    Gornet, Jean-Marc
    BULLETIN DU CANCER, 2015, 102 (02) : 117 - 125
  • [25] Analysis of TP53 gain of function mutations in metastatic castration-resistant prostate cancer.
    Sweeney, Patrick L.
    Lanka, Sree M.
    Jang, Albert
    Gupta, Kanika
    Caputo, Sydney
    Casado, Crystal
    Huang, Minqi
    Pocha, Olivia
    Hawkins, Maddie
    Lieberman, Alexandra
    Schwartz, Jennifer
    Jaeger, Ellen B.
    Miller, Patrick
    Barata, Pedro C.
    Layton, Jodi Lyn
    Lewis, Brian E.
    Ledet, Elisa M.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [26] ignificance of distinct specifically enriched missense TP53 mutations in prostate cancer
    Vasilevskaya, Irina
    McCann, Jennifer
    McNair, Christopher
    Neupane, Neermala Poudel
    Gallagher, Peter
    Knudsen, Karen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [27] Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?
    RoyBurman, P
    Zheng, JP
    Miller, GJ
    MOLECULAR MEDICINE TODAY, 1997, 3 (11): : 476 - 482
  • [28] Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer
    Mathiot, Laurent
    Nigen, Benoit
    Goronflot, Thomas
    Hiret, Sandrine
    Doucet, Ludovic
    Pons-Tostivint, Elvire
    Bennouna, Jaafar
    Denis, Marc G.
    Herbreteau, Guillaume
    Raimbourg, Judith
    CLINICAL LUNG CANCER, 2024, 25 (03) : 244 - 253.e2
  • [29] Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy
    Ruzzo, Annamaria
    Graziano, Francesco
    Palladino, Silvia
    Fischer, Nicholas W.
    Catalano, Vincenzo
    Giordani, Paolo
    Malkin, David
    Tamburrano, Tiziana
    Patriti, Alberto
    Petrelli, Filippo
    Sarti, Donatella
    Chiari, Rita
    ONCOLOGIST, 2024,
  • [30] Impact of germline TP53 mutations and polymorphisms in women with premenopausal breast cancer
    Samuel, Nardin
    Novokmet, Ana
    Hudson, Thomas J.
    Malkin, David
    CANCER RESEARCH, 2014, 74 (23)
12345